THOMPSON ELIZABETH H.Z. (EVP, Head of Research & Dev) sold 51.2% of their position (3.44K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $73.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001861477-26-000003
Officer· EVP, Head of Research & Dev
Since Mar 2026
-3.44K
Net shares
Net seller
$73.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.71K acquired · 10.15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.71K
Price / share
—
Trade value
—
% of position
New position
3/24/2026
0.00→6.71K
Common Stock
Direct
Shares
−3.44K
Price / share
$21.47
Trade value
$73.75K
% of position
51.2%
3/25/2026
6.71K→3.28K
Total
Net shares
+3.28K
Net value
-$73.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2026 | M · Option Exercise | +6.71K | — | — | New position | 0.00 | 6.71K |
| Common Stock Direct | 3/25/2026 | S · Sale | −3.44K | $21.47 | $73.75K | 51.2% | 6.71K | 3.28K |
| Total | +3.28K | -$73.75K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.71K shares
Shares
−6.71K
Strike price
Held after
20.15K
Exercisable
—
3/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.71K shares | 3/24/2026 | M · Option Exercise | −6.71K | — | 20.15K |